↓ Skip to main content

Dove Medical Press

Article Metrics

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
19 Mendeley
Title
Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients
Published in
Therapeutics and Clinical Risk Management, October 2013
DOI 10.2147/tcrm.s49754
Pubmed ID
Authors

Karl Stonecipher, Jenny Chia, Ahunna Onyenwenyi, Villanueva, David Hollander

Abstract

Dry eye is a multifactorial, symptomatic disease associated with ocular surface inflammation and tear film hyperosmolarity. This study was designed to assess patterns of topical cyclosporine ophthalmic emulsion 0.05% (Restasis®) use in dry eye patients and determine if there were any differences in use based on whether dry eye is physician-coded as a primary or nonprimary diagnosis.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 5%
Unknown 18 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 32%
Other 3 16%
Student > Bachelor 2 11%
Professor 1 5%
Student > Ph. D. Student 1 5%
Other 2 11%
Unknown 4 21%
Readers by discipline Count As %
Medicine and Dentistry 6 32%
Biochemistry, Genetics and Molecular Biology 3 16%
Chemistry 3 16%
Agricultural and Biological Sciences 1 5%
Psychology 1 5%
Other 0 0%
Unknown 5 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2013.
All research outputs
#3,111,735
of 4,506,051 outputs
Outputs from Therapeutics and Clinical Risk Management
#309
of 397 outputs
Outputs of similar age
#70,072
of 102,193 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#22
of 23 outputs
Altmetric has tracked 4,506,051 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 397 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 102,193 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.